What is atezolizumab, and how is it used?
Tecentriq is a prescription medicine used to treat adults with:
- a type of bladder and urinary tract cancer called urothelial carcinoma. Tecentriq may be used when your bladder cancer has spread or cannot be removed by surgery, and if you have any one of the following conditions:
- you are not able to take chemotherapy that contains a medicine called cisplatin, and your cancer tests positive for “PD-L1”, or
- you are not able to take chemotherapy that contains any platinum regardless of “PD-L1” status, or
- you have tried chemotherapy that contains platinum, and it did not work or is no longer working.
- a type of lung cancer called non-small cell lung cancer (NSCLC).
- Tecentriq may be used with bevacizumab and the chemotherapy medicines carboplatin and paclitaxel as your first treatment when your lung cancer:
- Tecentriq may be used alone when your lung cancer:
- has spread or grown, and
- you have tried chemotherapy that contains platinum, and it did not work or is no longer working.
- if your tumor has an abnormal “EGFR” or “ALK” gene, you should have also tried an FDA-approved therapy for tumors with these abnormal genes, and it did not work or is no longer working.
- a type of breast cancer called triple-negative breast cancer (TNBC). Tecentriq may be used with the medicine paclitaxel protein-bound when your breast cancer:
- has spread or cannot be removed by surgery, and
- your cancer tests positive for “PD-L1”.
- a type of lung cancer called small cell lung cancer (SCLC). Tecentriq may be used with the chemotherapy medicines carboplatin and etoposide as your first treatment when your lung cancer is a type called “extensive-stage SCLC,” which means that it has spread or grown.
It is not known if Tecentriq is safe and effective in children.
What are the side effects of atezolizumab?
WARNING
Immune-Mediated Pneumonitis: Withhold or permanently discontinue based on severity of pneumonitis.
- Immune-Mediated Hepatitis: Monitor for changes in liver function. Withhold or permanently discontinue based on severity of transaminase or total bilirubin elevation.
- Immune-Mediated Colitis: Withhold or permanently discontinue based on severity of colitis.
- Immune-Mediated Endocrinopathies:
- Hypophysitis: Withhold based on severity of hypophysitis.
- Thyroid Disorders: Monitor for changes in thyroid function. Withhold based on severity of hyperthyroidism.
- Adrenal Insufficiency: Withhold based on severity of adrenal insufficiency.
- Type 1 Diabetes Mellitus: Withhold based on severity of hyperglycemia.
- Infections: Withhold for severe or life-threatening infection.
- Infusion-Related Reactions: Interrupt, slow the rate of infusion, or permanently discontinue based on severity of infusion reactions.
- Embryo-Fetal Toxicity: Can cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus and use of effective contraception.
Tecentriq can cause serious side effects, including:
- feeling tired or weak
- nausea
- cough
- shortness of breath
- decreased appetite
The most common side effects of Tecentriq when used in lung cancer with other anti-cancer medicines include:
- feeling tired or weak
- nausea
- hair loss
- constipation
- diarrhea
- decreased appetite
The most common side effects of Tecentriq when used in triple-negative breast cancer with paclitaxel protein-bound include:
- hair loss
- tingling or numbness in hands or feet
- feeling tired
- nausea
- diarrhea
- low red blood cells (anemia)
- constipation
- cough
- headache
- low white blood cells
- vomiting
- decreased appetite
Tecentriq may cause fertility problems in females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility.
These are not all the possible side effects of Tecentriq. Ask your healthcare provider or pharmacist for more information. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW
Skin Cancer Symptoms, Types, Images See SlideshowWhat is the dosage of atezolizumab?
Administer Tecentriq as an intravenous infusion over 60 minutes. If the first infusion is tolerated, all subsequent infusions may be delivered over 30 minutes.
Your healthcare provider will give you Tecentriq into your vein through an intravenous (IV) line over 30 to 60 minutes.
- Tecentriq is usually given every 2, 3, or 4 weeks.
- Your healthcare provider will decide how many treatments you need.
- Your healthcare provider will test your blood to check you for certain side effects.
- If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment.
Urothelial Carcinoma
- Administer Tecentriq as:
- 840 mg every 2 weeks, 1200 mg every 3 weeks, or 1680 mg every 4 weeks
NSCLC
- Administer Tecentriq as a single agent as:
- 840 mg every 2 weeks, 1200 mg every 3 weeks, or 1680 mg every 4 weeks
- When administering in combination with bevacizumab and paclitaxel and carboplatin, administer Tecentriq 1200 mg every 3 weeks prior to chemotherapy or other antineoplastic drugs.
- Following completion of 4-6 cycles of paclitaxel and carboplatin, and if bevacizumab is discontinued, administer Tecentriq as:
- 840 mg every 2 weeks, 1200 mg every 3 weeks, or 1680 mg every 4 weeks
Metastatic Treatment of TNBC
Administer Tecentriq 840 mg, followed by 100 mg/m2 paclitaxel proteinbound. For each 28-day cycle, Tecentriq is administered on days 1 and 15, and paclitaxel protein-bound is administered on days 1, 8, and 15.
Small Cell Lung Cancer
- When administering with carboplatin and etoposide, administer Tecentriq 1200 mg every 3 weeks prior to chemotherapy.
- Following completion of 4 cycles of carboplatin and etoposide, administer Tecentriq as:
- 840 mg every 2 weeks, 1200 mg every 3 weeks, or 1680 mg every 4 weeks
Health News
- Advent of Electric Cars Is Already Improving Health
- Targeted Drug Tagrisso Could Be Advance Against Lung Cancer
- Knowing Someone Who's Been Ill or Died of COVID Pushes Folks to Get Vaccine: Study
- Kids Conceived Via IVF Have No Higher Risk of Heart Issues
- Shark Bites Are Declining Worldwide
More Health News »
Is atezolizumab safe to use while pregnant or breastfeeding?
Tecentriq can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Tecentriq.
Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with Tecentriq.
- You should use an effective method of birth control during your treatment and for at least 5 months after the last dose of Tecentriq.
- It is not known if Tecentriq passes into your breast milk. Do not breastfeed during treatment and for at least 5 months after the last dose of Tecentriq.
Summary
Atezolizumab (Tecentriq) is a chemotherapy drug used to treat urothelial carcinoma and other types of cancers. These include non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), and small cell lung cancer (SCLC). Side effects include nausea, diarrhea, hair loss, and fatigue, among others.
Multimedia: Slideshows, Images & Quizzes
-
Breast Cancer Awareness: Symptoms, Diagnosis, and Treatment
Learn about breast cancer causes, symptoms, tests, recovery, and prevention. Discover the types of treatments such as surgery and...
-
Lung Cancer: Early Signs, Symptoms, Stages
Learn about lung cancer early warning signs, symptoms and treatments. What causes stage IV lung cancer? Get more information on...
-
Bladder Cancer Symptoms, Stages, Treatments
Bladder cancer occurs when cancerous cells, often from the lining of the bladder, begin to multiply. Find more information about...
-
Lung Cancer Quiz: Signs and Symptoms
Lung cancer is the number one cause of cancer deaths in both men and women in the U.S. and worldwide. Get the facts about lung...
Related Disease Conditions
-
Lung Cancer
Lung cancer kills more men and women than any other form of cancer. Eight out of 10 lung cancers are due to tobacco smoke. Lung cancers are classified as either small-cell or non-small-cell lung cancers.
-
Bladder Cancer
Treatment for bladder cancer depends on the stage of the disease, the grade of the tumor, and the type of bladder cancer. Options for treatment include surgery, radiation therapy, chemotherapy, and biological therapy.
-
Triple-Negative Breast Cancer
Triple-negative breast cancer is more common in Hispanic and African-American women. Signs and symptoms include a lump in the armpit or breast, nipple discharge and inversion, and changes in the breast's skin. Treatment may incorporate surgery, chemotherapy, and radiation therapy.
-
Breast Cancer
Breast cancer is an invasive tumor that develops in the mammary gland. Breast cancer is detected via mammograms, breast self-examination (BSE), biopsy, and specialized testing on breast cancer tissue. Treatment of breast cancer may involve surgery, radiation, hormone therapy, chemotherapy, and targeted therapy. Breast cancer risk may be lowered by managing controllable risk factors. What you should know about breast cancer Breast cancer is the most common cancer among American women. One in every eight women in the United States develops breast cancer. There are many types of breast cancer that differ in their capability of spreading (metastasize) to other body tissues. The causes of breast cancer are unknown, although medical professionals have identified a number of risk factors. There are 11 common types of breast cancer and 4 uncommon types of breast cancer. Breast cancer early signs and symptoms include a lump in the breast or armpit, bloody nipple discharge, inverted nipple, orange-peel texture or dimpling of the breast's skin (peau d'orange), breast pain or sore nipple, swollen lymph nodes in the neck or armpit, and a change in the size or shape of the breast or nipple. Breast cancer can also be symptom free, which makes following national screening recommendations an important practice. Breast cancer is diagnosed during a physical exam, by a self-exam of the breasts, mammography, ultrasound testing, and biopsy. Treatment of breast cancer depends on the type of cancer and its stage (0-IV) and may involve surgery, radiation, or chemotherapy.
-
What Should I Do After an Unwanted Pregnancy?
There are a variety of options that may help you handle your situation. It might help you to visualize each option and decide how you feel about it. Consider reaching out to trained professionals or close friends if you get overwhelmed.
-
Small Cell Lung Cancer vs. Non-Small Cell Lung Cancer
Non-small cell lung cancers (NSCLC) consist of large cell carcinomas, adenocarcinomas, and squamous cell carcinomas. Small cell lung cancer (SCLC) usually starts in the bronchi and typically appears in those who smoke. SCLC and NSCLC are staged in different manners, and SCLC tends to metastasize more quickly than NSCLC. Signs and symptoms of NSCLC and SCLC include shortness of breath, coughing up blood, recurring lung infections, and chest pain. Treatment may involve radiation therapy, chemotherapy, and surgery.
Treatment & Diagnosis
Medications & Supplements
Subscribe to MedicineNet's Cancer Report Newsletter
By clicking "Submit," I agree to the MedicineNet Terms and Conditions and Privacy Policy. I also agree to receive emails from MedicineNet and I understand that I may opt out of MedicineNet subscriptions at any time.
Health Solutions From Our Sponsors

Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
All content from U.S. Food and Drug Administration prescribing information